FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Morphine Sulfate Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

Expand all

Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc. (New 03/05/2024)

Company Contact Information:
(973) 658-1839

Presentation	Posting Date	Related Information
Tablet, Extended Release, 60 mg (NDC 0228-4311-11)	03/05/2024
Tablet, Extended Release, 100 mg (NDC 0228-4323-11)	03/05/2024
Tablet, Extended Release, 200 mg (NDC 0228-4347-11)	03/05/2024

Actavis Pharma, Inc. (New 03/05/2024)

Company Contact Information:
(973) 658-1839

Presentation	Posting Date	Related Information
Tablet, Extended Release, 15 mg (NDC 0228-4270-11)	03/05/2024
Tablet, Extended Release, 30 mg (NDC 0228-4271-11)	03/05/2024

Teva Pharmaceuticals USA, Inc. (New 04/03/2024)

Company Contact Information:
(973) 658-1839

Presentation	Posting Date	Related Information
Tablet, Extended Release, 15 mg (NDC 0228-4270-11)	04/03/2024
Tablet, Extended Release, 30 mg (NDC 0228-4271-11)	04/03/2024
Tablet, Extended Release, 60 mg (NDC 0228-4311-11)	04/03/2024
Tablet, Extended Release, 100 mg (NDC 0228-4323-11)	04/03/2024
Tablet, Extended Release, 200 mg (NDC 0228-4347-11)	04/03/2024